Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,915,810
+$15,091,723 QoQ
Shares Held
89,209
+864.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#247
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$104,120,342
CallShares
549,100
PutValue
$97,521,566
PutShares
514,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIH Partners, LLLP holds $17,715,972 across 3 Drug Manufacturers - General names. AZN ranks #1 (95.5% of the industry book) .
All Filings in AZN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,120,342 | 549,100 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $97,521,566 | 514,300 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $16,915,810 | 89,209 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,824,087 | 9,249 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $67,074,522 | 340,100 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $81,984,354 | 415,700 | Put | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||